Biotech Derivatives Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: celeryroot.com who wrote (32)	3/2/1999 6:46:00 AM
From: LLCF	Read Replies (1) of 555

Please, this isn't "dialogue of the deaf" thread... I'm not going to answer your questions after this if you take that tone, going back and forth like this is counterproductive: <what "cancellation of agreement" ? there has been next to no activity in the warrents in the last 3 weeks> Eli Lilly informed LGND that they will not proceed with their agreement to develope oral Targretin and the two other first generation compounds in the RXR program sending the stock "crashing". < There were only 40 contracts written today according to CBOE. > You have been misinformed... if you would wait untill the information is available it would us going pack and forth and turning this into a thread like LGND. In the future I will not do this :) DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next